Avicanna To Bring Its CBD-Based Drugs To Latin America Via Chilean Pharma Partner

Cannabis-focused biopharmaceutical company Avicanna Inc. AVCN AVCNF 0NN revealed Friday that it has partnered with Chile's Knop Laboratorios S.A. to supply a range of cannabinoid-based active pharmaceutical ingredients for the manufacturing and commercialization of proprietary cannabinoid-based pharmaceutical products in Latin America.

The deal between Avicanna's majority-owned subsidiary Santa Marta Golden Hemp and the established Chilean pharmaceutical company further solidifies Avicanna's and Knop's collaboration.

Since 2018, Avicanna and Knop have developed a collaborative enterprise that has led to commercial imports of Avicanna's API, including CBD and THC, which have been used in the development, production and commercialization of several cannabinoid-based products.

Recent Moves

The latest move follows Avicanna's partnership with an Argentine pharmaceutical company. In November, the company agreed to register and commercialize its proprietary cannabinoid-based pharmaceutical preparations through the licensing of its intellectual property and supply of its active pharmaceutical ingredients.

In the meantime, Avicanna also expanded its Rho Phyto-branded medical cannabis products into the Caribbean region after a successful initial export to its distribution partner, Bryden Stokes Limited in Barbados.

To wrap up the previous year, the company launched its re+PLAY sports recovery-based CBD brand through a partnership with Harrington Wellness, founded by NBA veteran Al Harrington.

The company recently revealed that the third quarter was its most successful to date, with roughly CA$1 ($987,967) in revenue, representing a gross revenue increase of 24% sequentially and 260% year-over-year.

AVCNF Price Action

Avicenna'sa shares traded 7.14% higher at $0.6 per share at the time of writing on Friday.

Photo: Courtesy of Cytonn Photography on Unsplash

Market News and Data brought to you by Benzinga APIs
Posted In: CannabisNewsPenny StocksTopicsMarketsGeneralAl Harringtoncbd cannabisChilesupply deal
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

The Top Cannabis Event In New Jersey

Join the Benzinga Cannabis Market Spotlight in New Jersey on June 17th! Grow your business, raise money and capitalize on the booming NJ recreational market. Don’t miss this must-attend event in New Brunswick. Secure your tickets now. Very few spots are left. Use the code "JAVIER20" for 20% off!